Latino community not aware of Alzheimer's disease: Survey

NewsGuard 100/100 Score

According to the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey, which was funded by MetLife Foundation and released today during National Hispanic Heritage Month, 64 percent of survey respondents felt that the Latino community is not very aware or not at all aware of Alzheimer's disease.  This information, coupled with the finding that Hispanics are one and one-half times more likely to have Alzheimer's disease and dementia than whites, demonstrates the need for additional Alzheimer's information and support services in the Latino community.    

From the Alzheimer's Association "Hispanic Perceptions of Alzheimer's Disease" survey:

  • While more than 90 percent of those surveyed knew that Alzheimer's is a progressive brain disease that causes memory loss and problems with thinking and behavior, only half (53 percent) knew it is a fatal disease.  
  • Seventy three percent of those surveyed felt that knowing the 10 Warning Signs of Alzheimer's is very important.  However,
    • Only thirty nine percent of people survey knew that trouble understanding visual images and spatial relationships is a warning sign of Alzheimer's.
    • Only thirty eight percent of people survey knew that challenges in planning or solving problems is warning sign of Alzheimer's.  
    • Only thirty four percent of those surveyed knew that withdrawal from work or social activities is a warning sign of Alzheimer's.  
    • Fifty four percent of those surveyed incorrectly thought forgetting which day it is but remembering later is a warning sign of Alzheimer's.
    • Forty percent of those surveyed incorrectly thought losing things from time to time is a warning sign of Alzheimer's.

Despite this knowledge gap, at 71 percent the majority of survey respondents indicated that they would like to learn more about Alzheimer's warning signs.  To help meet those needs, the Alzheimer's Association has created a Spanish-language educational workshop entitled "Know the 10 Signs."  The workshop, which is currently available to people with the disease and their families from the more than 70 Alzheimer's Association Chapters nationwide, explores the 10 Warning Signs of Alzheimer's disease with participants.  The "Know the 10 Signs" Spanish-language workshop will also be made available to the public at www.alz.org/espanol this fall.    

"Alzheimer's disease is not normal aging.  It is a complex brain disease that impacts much more than memory," said Janis Robinson, Director of Diversity and Strategic Collaborations at the Alzheimer's Association.  "Knowing the 10 Warning Signs of Alzheimer's is critical to early detection and receiving the best care possible, so it is imperative that we are inclusive as this public health crisis explodes across the country, including in our diverse communities."

When speaking about the barriers to seeking further care, the majority of respondents (39 percent) said the person exhibiting warnings signs do not believe they have a problem.  Other barriers include concern about reaction by the person exhibiting warning signs and others, preference to not think about it and lack of a cure.  

"Alzheimer's affects millions of individuals, and the general public relies upon the Alzheimer's Association as a leading resource for accurate information," said Dennis White, president and CEO of MetLife Foundation. "These findings help to heighten the importance of providing the Hispanic community with much-needed information and help raise awareness of Alzheimer's disease."

SOURCE Alzheimer's Association

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neuroimaging and network modeling tools shed light on Alzheimer's disease in animal models